Printed from Voxsanity (voxsanity.com.au) — NCT07420023 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Type 2 Diabetes Trial, Recruiting
NCT07420023
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a written consent form agreeing to take part
- You are between 18 and 45 years old
- Your Body Mass Index (BMI) — a measure based on your height and weight — falls between 25 and 30, which is considered "overweight"
- Your waist measurement is more than 94cm (about 37 inches) if you are male, or more than 80cm (about 31.5 inches) if you are female
- Your weight has stayed roughly the same (changed less than 5%) over the past three months
- You are generally in good health, with a blood pressure reading below 160/100, as confirmed by a study doctor
- You are willing to stop taking dietary supplements, prebiotics, probiotics, or fibre supplements at least four weeks before the study starts and throughout the study
- You are willing to avoid intense, goal-focused exercise on the days you receive the study products
- You are willing to eat the specific study foods and follow the meal plan every day for the whole study
Who may not be able to join:
- Women who are pregnant, breastfeeding, post-menopausal, or planning to become pregnant during the study
- Anyone who has taken antibiotics in the three months before the study starts
- Anyone currently taking certain medications (such as anti-inflammatory drugs, antacids, blood pressure medicines, steroids, laxatives, blood thinners, or immunosuppressants) — though some exceptions may apply if your dose has been stable for at least two months (confirm with trial site)
- Anyone with a current or recent history of drug or alcohol misuse
- Anyone who regularly drinks more than two alcoholic drinks per day (more than 28g of alcohol daily)
- Anyone who follows a vegetarian or vegan diet
- Anyone who typically eats more than 30g of dietary fibre per day
- Anyone who has made major changes to their diet in the three months before the study
- Anyone planning significant changes to their diet, exercise habits, or travel plans during the study
- Anyone with a clinically diagnosed eating disorder
- Anyone with a food allergy or intolerance (such as to eggs, gluten, nuts, or dairy) that would prevent them from eating the study foods
- Anyone with an active digestive (gastrointestinal) condition or who has had digestive surgery in the past
- Anyone with a significant ongoing or long-term illness, including conditions such as diabetes, heart disease, Crohn's disease, IBS, cancer, HIV, or other serious health conditions
- Anyone with a severely weakened immune system (for example, due to HIV, an organ transplant, long-term steroid use, or recent chemotherapy or radiotherapy)
- Anyone with a serious or end-stage disease affecting major organs
- Anyone with active breathing or heart problems
- Anyone who has recently experienced unexplained weight loss, rectal bleeding, sudden changes in bowel habits, or severe stomach pain in the three months before the study
- Anyone the study doctor feels is unlikely to be able to follow the study requirements
- Anyone currently taking part in another experimental drug study, or who has completed another trial within the last 30 days
- Anyone who regularly does intense or vigorous exercise
- Anyone who currently smokes or vapes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Jens Walter, PhD, University College Cork; University of Alberta
Phone: +353 (0)86 199 2919
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
University College Cork
Registry
ClinicalTrials.gov
Start date
18 August 2025
Est. completion
1 May 2026
Where this trial is recruiting
🇮🇪 Ireland
Primary endpoints
Impact on Postprandial Glycaemic Response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.